Genetically engineered NK cells can be seen here producing chimeric antigen receptors (CARs) on their surface.

Natural killer cells have the advantage of being able to attack tumor cells without priming or prior activation.

Sequence created by hybridmedical for a series in which oncologists discuss the advantages of NK-based immunotherapies currently in clinical trials.

Source: hybridmedical